DK1917959T3 - En ny medicinsk anvendelse af alfa-ketoglutarat - Google Patents

En ny medicinsk anvendelse af alfa-ketoglutarat

Info

Publication number
DK1917959T3
DK1917959T3 DK07460015.6T DK07460015T DK1917959T3 DK 1917959 T3 DK1917959 T3 DK 1917959T3 DK 07460015 T DK07460015 T DK 07460015T DK 1917959 T3 DK1917959 T3 DK 1917959T3
Authority
DK
Denmark
Prior art keywords
bacteria
ureolytic
ketoglutarate
ureolytic bacteria
infections
Prior art date
Application number
DK07460015.6T
Other languages
English (en)
Inventor
Danuta Kruszewska
Original Assignee
Danuta Kruszewska
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danuta Kruszewska filed Critical Danuta Kruszewska
Application granted granted Critical
Publication of DK1917959T3 publication Critical patent/DK1917959T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
DK07460015.6T 2006-07-03 2007-07-03 En ny medicinsk anvendelse af alfa-ketoglutarat DK1917959T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL380103A PL226695B1 (pl) 2006-07-03 2006-07-03 Środek do zastosowania w zapobieganiu i/lub hamowaniu kolonizacji Helicobacter pylori, zastosowanie soli kwasu alfa‑ketoglutarowego z metalami alkalicznymi i ziem alkalicznych do wytwarzania środka leczniczego oraz dodatku do żywności do zapobiegania i/lub hamowania kolonizacji Helicobacter pylori

Publications (1)

Publication Number Publication Date
DK1917959T3 true DK1917959T3 (da) 2011-05-09

Family

ID=38984524

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07460015.6T DK1917959T3 (da) 2006-07-03 2007-07-03 En ny medicinsk anvendelse af alfa-ketoglutarat

Country Status (10)

Country Link
US (1) US20100124537A1 (da)
EP (1) EP1917959B1 (da)
AT (1) ATE495738T1 (da)
DE (1) DE602007012036D1 (da)
DK (1) DK1917959T3 (da)
ES (1) ES2360142T3 (da)
HR (1) HRP20110268T1 (da)
IL (1) IL233342A (da)
PL (2) PL226695B1 (da)
SI (1) SI1917959T1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7803817B2 (en) 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
US7981908B2 (en) 2005-05-11 2011-07-19 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion
ES2511792T3 (es) 2006-07-25 2014-10-23 Vecta Ltd. Composiciones y métodos para la inhibición de la secreción de ácido gástrico usando derivados de pequeños ácidos dicarboxílicos en combinación con IBP
SE0602446L (sv) * 2006-11-16 2008-05-17 Entress Ab Ny användning av kända farmakologiskt aktiva kemiska sammansättningar
HUE033223T2 (hu) 2010-11-29 2017-11-28 Eurochit Danuta Kruszewska Új nanotermék kórmegelõzésben, diagnosztikában, valamint orvosi és állatorvosi kezelésben való alkalmazásra
CN104684565A (zh) 2012-05-29 2015-06-03 达努塔·克鲁谢夫斯卡 在人类和兽医的预防和医疗中有用的、包含罗伊氏乳杆菌dan080的纳米产品及其医疗用途
EP2674162A1 (en) 2012-05-29 2013-12-18 Danuta Kruszewska Nanoproduct comprising lactobacillus reuteri dan080 useful in prophylaxis and medicine, both human and veterinary and medical use of the same
US9592211B2 (en) 2012-09-19 2017-03-14 Grespo Ab Compositions for improvement of brain function
CN103923900B (zh) * 2014-04-14 2016-03-23 江南大学 一种黄酒用双功能酶交联酶聚集体的制备与应用
WO2018064468A1 (en) * 2016-09-30 2018-04-05 The Regents Of The University Of California Alpha-ketobutyrate, alpha-ketoglutarate, and 2-hydroxybutyrate for stimulating hair growth
IL308093A (en) * 2017-04-25 2023-12-01 Buck Inst Res Aging Formulations to extend life span and health
AU2019350699B2 (en) 2018-09-25 2024-05-23 Ponce De Leon Health Designated Activity Company Process of making calcium alpha-ketoglutarate
EP3870184A4 (en) * 2018-10-24 2022-07-20 Ponce de Leon Health Designated Activity Company NICOTINAMIDE RIBOSIDE COMPOSITIONS TO PROLONG HEALTHY LIFE
WO2022006500A1 (en) * 2020-07-02 2022-01-06 Ponce De Leon Health Designated Activity Company Compositions and methods for treating crp-mediated diseases
CN115340313B (zh) * 2022-01-17 2023-04-18 浙江理工大学 一种物理复合微生物技术强化再生骨料方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4919855B1 (da) 1970-10-06 1974-05-21
US4256731A (en) * 1978-03-23 1981-03-17 Beecham, Inc. Oral Compositions
US5028412A (en) * 1987-05-01 1991-07-02 Purdue Research Foundation Oral compositions comprising anti-calculus agents
US5817294A (en) * 1990-11-02 1998-10-06 Arnold; Michael J. Plaque adsorbent oral composition and method
JP2002529545A (ja) * 1998-11-06 2002-09-10 ユニベルシテ ドゥ モントリオール バイオフィルムを除去するための改良型の殺菌性及び非殺菌性溶液
FR2822704B1 (fr) * 2001-03-29 2005-02-18 Chiesi Sa Sels de cetoacides et d'acides amines gastroresistants et leur utilisation pour la preparation de medicaments
US7122578B2 (en) * 2001-09-11 2006-10-17 Alain Martin Method and composition for treating mammalian diseases and injuries which cause pain, erythema, swelling, crusting, ischemia scarring and excess white blood cell infiltration
SE0200256D0 (sv) * 2001-12-21 2002-01-29 Gramineer Internat Ab New composition, methods and use
PL368572A1 (en) * 2004-06-17 2005-12-27 Sgp & Sons Ab Pharmaceutical compound for prevention and therapy of increased level of cholesterol, ldl and triglycerides as well as application of the pharmaceutical compound as an agent acting against atherosclerosis and used in circulatory system affections
WO2007082914A2 (en) * 2006-01-19 2007-07-26 Entress Ab Method of diagnosis and method of treatment
US7803817B2 (en) * 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
CN101309678B (zh) 2005-11-15 2011-04-20 安特瑞斯公司 用于与软骨损伤有关的应用的药物

Also Published As

Publication number Publication date
SI1917959T1 (sl) 2011-05-31
EP1917959A1 (en) 2008-05-07
PL1917959T3 (pl) 2011-06-30
PL226695B1 (pl) 2017-08-31
PL380103A1 (pl) 2008-01-07
US20100124537A1 (en) 2010-05-20
EP1917959B1 (en) 2011-01-19
DE602007012036D1 (de) 2011-03-03
IL233342A (en) 2016-05-31
HRP20110268T1 (hr) 2011-05-31
ATE495738T1 (de) 2011-02-15
IL233342A0 (en) 2014-08-31
ES2360142T3 (es) 2011-06-01

Similar Documents

Publication Publication Date Title
DK1917959T3 (da) En ny medicinsk anvendelse af alfa-ketoglutarat
Wang et al. Evaluation of the antibacterial potential of liquid and vapor phase phenolic essential oil compounds against oral microorganisms
BRPI0902901B8 (pt) bacteriófago e composição antibacteriana, alimento para animais, água potável, desinfetante, agente de limpeza e método para tratamento de doenças infecciosas compreendendo o mesmo
BR112013004206A2 (pt) novo bacteriófago isolado contendo atividade bactericida específica de e. coli e composição antibacteriana que compreende o mesmo
AU2010321992A1 (en) Biofilm disruptive compositions
JP2011530534A5 (da)
HRP20090583T1 (hr) Novi laktobacil, pripravak laktobacila koji se aktivira u živom organizmu, te preventivno ili terapijsko sredstvo protiv infekcija kod živog organizma
JP2019524877A5 (da)
BR112021022632A2 (pt) Composições e métodos para tratar condições pulmonares relacionadas a biofilmes
CA3143793C (en) Biofilm disruption
CN103690937A (zh) 一种含海洋生物成分的儿童用龋齿口腔喷剂及其制备方法
BR112019003890A2 (pt) uso de oligossacarídeos de leite humano em engordamento de bezerros
NO993774D0 (no) Carbapenem-forbindelse, anvendelse herav og intermediær forbindelse herav
JP2010095489A (ja) 病原性細菌の毒素産生抑制剤
Ponnuraj et al. Influence of Limonia acidissima L. against the biofilm forming Aeromonas hydrophila isolated from fresh water fishes
Kishimoto et al. Mechanical tooth cleaning before chlorhexidine application
Ebenezer et al. A surge in anti-bacterial and anti-inflammatory activity of Sepia pharaonis ink extract in different solvents-an in-vitro study
Ismail et al. Silver nanoparticles and sodium hypochlorite inhibitory effects on biofilm produced by Pseudomonas aeruginosa from poultry farms
JP2010513431A5 (da)
Moses-Otutu et al. Microbial contamination of tooth brushes and tooth brush keeping places among apparently healthy individuals in Egor LGA, Benin City
EA201892278A1 (ru) Анбитактериальные биароматические производные с оксетан-3-илокси замещением
RU2583890C2 (ru) Способ лечения гингивитов, пародонтитов и зубного камня у собак
Guggenbichler Dramatic increase of multi-resistant microorganisms is self-inflicted. Effective and easy solutions are available
Fatoni et al. Conventional and comprehensive oral hygiene procedures using Chlorhexidine 0.2% in patients with mechanical ventilator
Anup et al. Toothbrush contamination a review of Indian literature